- Transition of Monoclonal Antibody Bebtelovimab, 175mg from Government Supplied to the Commercial Market
- Home and Community Based Settings (HCBS) Lifespan Project Listening Sessions
- ATTENTION Correction to Section 92, Section 13, and Section 17 message to Providers: Passthrough process now required if organizations jointly serve an Opioid Health Home (OHH) Member
- 835 and RA Delays
- Re-entry Update #11
- CLARIFICATION regarding Sections 13, 17, 28, 65, 92 Draft Rate Model(s) Public Review and Comment message
- Pfizer and Moderna Bivalent COVID-19 Vaccines Authorized to use as Booster Doses
- Tribal Self-Attestation, CR 108474
- ATTENTION Section 92, Section 13, and Section 17 Providers: Passthrough process now required if organizations jointly serve an Opioid Health Home (OHH) Member
- Attention Providers of Sections 13, 17, 28, 65, 92 Draft Rate Model(s) Public Review and Comment
DHHS → node